Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010 Apr;33(4):754-6.
doi: 10.2337/dc09-1938. Epub 2010 Jan 19.

Comparison of radioimmunoprecipitation with luciferase immunoprecipitation for autoantibodies to GAD65 and IA-2beta

Peter D Burbelo  1 , Hiroki Hirai, Alexandra T Issa, Albert Kingman, Ake Lernmark, Sten-A Ivarsson, Abner L Notkins, Michael J Iadarola
Affiliations

Comparison of radioimmunoprecipitation with luciferase immunoprecipitation for autoantibodies to GAD65 and IA-2beta

Peter D Burbelo et al. Diabetes Care. 2010 Apr.

Abstract

Objective: To compare the sensitivity and specificity of luciferase immunoprecipitation (LIPS) with radioimmunoprecipitation (RIP) for the measurement of autoantibodies to the type 1 diabetes autoantigens glutamic acid decarboxylase 65 (GAD65) and insulinoma-associated protein (IA)-2beta.

Research design and methods: Sera from 49 type 1 diabetic patients and 100 nondiabetic control subjects from Diabetes Antibody Standardization Program 2007 were used to screen for autoantibodies to GAD65. An additional 200 type 1 diabetic patients and 200 nondiabetic control subjects were used to validate the GAD65 results and screen for autoantibodies to IA-2beta.

Results: LIPS showed equal sensitivity and specificity to RIP for detecting autoantibodies to GAD65 and IA-2beta. Receiver-operating characteristic analysis revealed that the detection of autoantibodies to GAD65 and IA-2beta by LIPS and RIP were not statistically different.

Conclusions: The LIPS assay does not require the use of radioisotopes or in vitro transcription/translation and is a practical alternative at the clinical level for the RIP assay.

PubMed Disclaimer

Figures

Figure 1
Figure 1
GAD65 autoantibodies as determined by LIPS (A) and RIP (B) and IA-2β autoantibodies as determined by LIPS (C) and RIP (D). Dotted lines represent 3 SDs above the mean of the nondiabetic control sera. E: ROC analysis showing the area under the curve for GAD autoantibodies by LIPS (0.929 [95% CI 0.875–0.964]) and by RIP (0.941 [0.891–0.973]). There was no statistical difference (P = 0.592). F: ROC analysis showing the area under the curve for IA-2β autoantibodies by LIPS (0.844 [0.804– 0.879]) and by RIP (0.807 [0.763–0.849]). There was no statistical difference (P = 0.062).
See this image and copyright information in PMC

References

    1. Achenbach P, Bonifacio E, Williams AJ, Ziegler AG, Gale EA, Bingley PJ. Autoantibodies to IA-2beta improve diabetes risk assessment in high-risk relatives. Diabetologia 2008;51:488–492 - PubMed
    1. Notkins AL, Lernmark A. Autoimmune type 1 diabetes: resolved and unresolved issues. J Clin Invest 2001;108:1247–1252 - PMC - PubMed
    1. Notkins AL. New predictors of disease: molecules called predictive autoantibodies appear in the blood years before people show symptoms of various disorders: tests that detected these molecules could warn of the need to take preventive action. Sci Am 2007;296:72–79 - PubMed
    1. Burbelo PD, Hirai H, Leahy H, Lernmark A, Ivarsson SA, Iadarola MJ, Notkins AL. A new luminescence assay for autoantibodies to mammalian cell-prepared insulinoma-associated protein 2. Diabetes Care 2008;31:1824–1826 - PMC - PubMed
    1. Li Q, Borovitskaya AE, DeSilva MG, Wasserfall C, Maclaren NK, Notkins AL, Lan MS. Autoantigens in insulin-dependent diabetes mellitus: molecular cloning and characterization of human IA-2 beta. Proc Assoc Am Physicians 1997;109:429–439 - PubMed

Publication types

MeSH terms

Substances